Fresenius Kabi Australia Pty Ltd.
🇦🇺Australia
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
137
TGA:137
Drug Approvals
NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 1 mg/1 mL concentrated injection ampoule (424893)
- Product Name
- NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 1 mg/1 mL concentrated injection ampoule
- Approval Date
- Dec 18, 2024
TGA
NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 10 mg/10 mL concentrated injection ampoule (424892)
- Product Name
- NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 10 mg/10 mL concentrated injection ampoule
- Approval Date
- Dec 18, 2024
TGA
NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL concentrated injection ampoule (424894)
- Product Name
- NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL concentrated injection ampoule
- Approval Date
- Dec 18, 2024
TGA
BENZYLPENICILLIN KABI benzylpenicillin sodium 1200 mg powder for injection vial (409012)
- Product Name
- BENZYLPENICILLIN KABI benzylpenicillin sodium 1200 mg powder for injection vial
- Approval Date
- May 3, 2024
TGA
BENZYLPENICILLIN KABI benzylpenicillin sodium 600 mg powder for injection vial (409010)
- Product Name
- BENZYLPENICILLIN KABI benzylpenicillin sodium 600 mg powder for injection vial
- Approval Date
- May 3, 2024
TGA
BENZYLPENICILLIN KABI benzylpenicillin sodium 3000 mg powder for injection vial (409011)
- Product Name
- BENZYLPENICILLIN KABI benzylpenicillin sodium 3000 mg powder for injection vial
- Approval Date
- May 3, 2024
TGA
AMIKACIN KABI amikacin (as sulfate) 500 mg/100 mL solution for injection bottle (408406)
- Product Name
- AMIKACIN KABI amikacin (as sulfate) 500 mg/100 mL solution for injection bottle
- Approval Date
- Apr 9, 2024
TGA
AMIKACIN KABI amikacin (as sulfate) 1000 mg/200 mL solution for injection bottle (408407)
- Product Name
- AMIKACIN KABI amikacin (as sulfate) 1000 mg/200 mL solution for injection bottle
- Approval Date
- Apr 9, 2024
TGA
AMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle (408399)
- Product Name
- AMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle
- Approval Date
- Apr 9, 2024
TGA
SUGAMMADEX KABI sugammadex (as sodium) 500 mg/5 mL solution for injection vial (405170)
- Product Name
- SUGAMMADEX KABI sugammadex (as sodium) 500 mg/5 mL solution for injection vial
- Approval Date
- Jan 24, 2024
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
Clinical Trials
No trials found
News
No news found